However, some may take it off-label (meaning for a use the FDA has not approved) to treat bipolar disorder. Various studies ...

And many patients who wind up with the label of bipolar disorder are initially misdiagnosed with unipolar depression. Misdiagnosed patients like Ola often look back on years of worsening symptoms and ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

BMS swooped on Karuna towards the end of last year, shortly after AbbVie agreed an $8.7 billion deal to acquire Cerevel ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Becoming a mother is a happy feeling, and only a mother can understand this feeling. But in today’s time, a woman often loses ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Doctors sometimes use lithium to treat schizophrenia. However, it is not a primary treatment method and evidence of its ...

You may have heard about ketamine in the news, but did you know that the right dose of this medicine can stimulate your brain ...

The death this summer of a mentally ill Scranton, Pennsylvania, man who authorities said was killed by his roommate at ...